GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bolt Biotherapeutics Inc (FRA:6LP) » Definitions » Deferred Policy Acquisition Costs

Bolt Biotherapeutics (FRA:6LP) Deferred Policy Acquisition Costs


View and export this data going back to 2021. Start your Free Trial

What is Bolt Biotherapeutics Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Bolt Biotherapeutics (FRA:6LP) Business Description

Industry
Traded in Other Exchanges
Address
900 Chesapeake Drive, Redwood, CA, USA, 94063
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems.